Editas Medicine Statistics

Total Valuation

Editas Medicine has a market cap or net worth of $121.38 million. The enterprise value is -$111.83 million.

Market Cap	121.38M
Enterprise Value	-111.83M

Important Dates

The next estimated earnings date is Friday, May 16, 2025, before market open.

Earnings Date	May 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Editas Medicine has 83.71 million shares outstanding. The number of shares has increased by 8.39% in one year.

Current Share Class	83.71M
Shares Outstanding	83.71M
Shares Change (YoY)	+8.39%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	61.62%
Float	83.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.54
Forward PS	22.05
PB Ratio	0.86
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.26.

Current Ratio	3.75
Quick Ratio	3.71
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -98.10% and return on invested capital (ROIC) is -53.82%.

Return on Equity (ROE)	-98.10%
Return on Assets (ROA)	-35.52%
Return on Invested Capital (ROIC)	-53.82%
Return on Capital Employed (ROCE)	-90.38%
Revenue Per Employee	$131,358
Profits Per Employee	-$963,793
Employee Count	246
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.20% in the last 52 weeks. The beta is 2.15, so Editas Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	-71.20%
50-Day Moving Average	1.42
200-Day Moving Average	2.43
Relative Strength Index (RSI)	51.07
Average Volume (20 Days)	1,762,339

Short Selling Information

The latest short interest is 12.67 million, so 15.13% of the outstanding shares have been sold short.

Short Interest	12.67M
Short Previous Month	12.68M
Short % of Shares Out	15.13%
Short % of Float	15.19%
Short Ratio (days to cover)	5.89

Income Statement

In the last 12 months, Editas Medicine had revenue of $32.31 million and -$237.09 million in losses. Loss per share was -$2.88.

Revenue	32.31M
Gross Profit	-166.93M
Operating Income	-238.92M
Pretax Income	-193.45M
Net Income	-237.09M
EBITDA	-233.11M
EBIT	-238.92M
Loss Per Share	-$2.88

Full Income Statement

Balance Sheet

The company has $269.91 million in cash and $35.03 million in debt, giving a net cash position of $234.88 million or $2.81 per share.

Cash & Cash Equivalents	269.91M
Total Debt	35.03M
Net Cash	234.88M
Net Cash Per Share	$2.81
Equity (Book Value)	134.27M
Book Value Per Share	1.62
Working Capital	212.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$210.28 million and capital expenditures -$8.83 million, giving a free cash flow of -$219.11 million.

Operating Cash Flow	-210.28M
Capital Expenditures	-8.83M
Free Cash Flow	-219.11M
FCF Per Share	-$2.62

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-739.37%
Pretax Margin	-733.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Editas Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.39%
Shareholder Yield	-8.39%
Earnings Yield	-192.68%
FCF Yield	-178.06%

Analyst Forecast

The average price target for Editas Medicine is $7.69, which is 430.35% higher than the current price. The consensus rating is "Buy".

Price Target	$7.69
Price Target Difference	430.35%
Analyst Consensus	Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	-10.02%
EPS Growth Forecast (5Y)	-13.97%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Editas Medicine has an Altman Z-Score of -6.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.26
Piotroski F-Score	1